STOCK and FLOW. ANZDATA Registry 2011 Report CHAPTER 1 STOCK & FLOW. Blair Grace Kylie Hurst Stephen McDonald 1-1

Similar documents
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell

Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

CHAPTER 6 PERITONEAL DIALYSIS

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Burden of end-stage renal disease

Overview of Organ Donation

Chapter 1. Organ Donation. in Australia and New Zealand

Deceased Organ Donation SECTION 2

The About: Documents

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT

Chapter 9. Kidney Donors. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

National Joint Replacement Registry. Mortality following Primary Hip and Knee Arthroplasty

CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT

National Joint Replacement Registry. Metal and Ceramic Bearing Surface in Total Conventional Hip Arthroplasty

Dialysis and Transplantation Audit

Hepatitis B and C in Australia. Annual Surveillance Report Supplement 2016

eviq.org.au A/Prof Jeremy Shapiro Cabrini Hematology and Oncology Centre Chair EVIQ Medical Oncology Committee PCPA 2017 Jeremy Shapiro

Princess Alexandra Hospital, Brisbane

New perspec)ves on withdrawal from dialysis. Jennifer Chan, Phil Clayton, Stephen McDonald, John Agar, Ma?hew Jose

Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand

NATIONAL ORAL HEALTH PLAN MONITORING GROUP. KEY PROCESS AND OUTCOME PERFORMANCE INDICATORS Second follow-up report

Copyright Australian Hearing Demographic Details

State of Cardiovascular Health in the NT DR MARCUS ILTON

Identifying Problem Gamblers in Gambling Venues

THE ECONOMIC IMPACT OF END-STAGE KIDNEY DISEASE IN AUSTRALIA PROJECTIONS TO 2020

An epidemic of renal failure among Australian Aboriginals

Overview of Indigenous health 2004

2016 CELEBRATING 15 YEARS OF DATA REPORT NATIONAL JOINT REPLACEMENT REGISTRY. Metal and Ceramic Bearing Surface in Total Conventional Hip Arthroplasty

AIHW Dental Statistics and Research Unit Research Report No. 26 Access to dental services among Australian children and adults

National Cross Cultural Dementia Network (NCCDN) A Knowledge Network of value

CHAPTER 12 CARDIOVASCULAR MORTALITY OF PATIENTS WHO COMMENCE DIALYSIS WITHOUT CLINICAL EVIDENCE OF CARDIOVASCULAR DISEASE

Acceptance onto dialysis guidelines: St George Hospital

Australia Bridging the gap

Supporting Aboriginal and Torres Strait Islander Access to Radiation Oncology Services

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

New Zealand. Dialysis and Transplantation Audit

Heart Donation in Australia and New Zealand

Allocation of deceased donor kidneys. Phil Clayton NSW Renal Group 14 June 2012

Drug-related hospital stays in Australia

HIV in Australia Annual surveillance short report 2018

Organ Waiting Lists in Australia and New Zealand

About kidney transplant care in New Zealand

Rural and remote health care research funding at NHMRC opportunities and barriers

Kidney Transplant Activity New Zealand

BCG vaccine and tuberculosis

CANCER IN AUSTRALIA. Australasian Association of Cancer Registries

2002 AUSTRALIAN BUREAU OF STATISTICS DATA ON ACCIDENTAL DRUG-INDUCED DEATHS DUE TO OPIOIDS

Breaking the chain of transmission: Nurses' role in preventing STI's

Table S1. Clinical outcomes of the acceptable mismatch allocation model.

Kidney Transplant Activity New Zealand

Organ Data. Chapter 5

The early diagnosis of children

Aboriginal and Torres Strait Islander women and cervical cancer prevention. Menzies School of Health

MRJ Baldock & JE Woolley Roadside drug testing in Australia: the absence of crash-based evaluations

Drug-related hospital stays in Australia

Breast Screening and Breast Cancer Survival in Aboriginal and Torres Strait Islander Women of Australia

Wendy Washington & Anne Graham. Nephrology Nurse Practitioners

Association between causes of peritoneal dialysis technique failure and all-cause mortality

Monitoring hepatitis C treatment uptake in Australia

What's Needed to Close the Indigenous Health Inequality Gap!

New survey highlights impact of Aboriginal and Torres Strait Islander mental health conditions

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Accidental drug-induced deaths due to opioids in Australia, 2013

14. EMPLOYMENT Occupational segregation Commonwealth Employment by industry for males and females who identify as

Deceased Organ Transplant Waiting List SECTION 11

Statement about the release of the National Ice Taskforce Report, release of two Review report and various announcements by the Australian Government

Chapter 5. Organ Data. ANZOD Registry Annual Report. Data to 31-Dec-2014

Annual Surveillance Report 2014 Supplement

Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people. Annual Surveillance Report 2017

The first year counts: cancer survival among Indigenous and non-indigenous Queenslanders

Normative data for adults referred for specialist pain management in Australia

SHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson

Breast screening among Indigenous women in Australia. Sue Moore Menzies School of Health Research

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

Arm yourself against Hep B! Vaccinate

AUSTRALIAN BEEF EATING QUALITY INSIGHTS 2017

Drug related hospital stays in Australia

Peritoneal dialysis in rural Australia

Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012

Statewide Infant Screening - Hearing (SWISH) Elisabeth Murphy Lara Harvey Carlie Naylor NSW Health Department

Menzies. Aboriginal Health in 21st century 6/07/2014. Menzies Vision. Research Divisions. Where do we work? Making a Difference in Indigenous Health

The Secretary 09 February 2018 Queensland Law Reform Commission PO Box George Street Post Shop QLD 4003

A tale of two specialties

Evaluating strategies for STI management in remote Indigenous communities of Australia

Transcription:

CHAPTER 1 STOCK & FLOW Blair Grace Kylie Hurst Stephen McDonald 1-1

ANZDATA Registry 2011 Report The number of new patients in Australia decreased slightly to 2257 in 2010. While there is variation in this rate from year to year, the rate has clearly stabilised over the period from 2006 and possibly decreased over the period from 2008 to 2010. Reflecting both the changes in numbers of new patients and higher number of transplants, the number of prevalent dialysis patients (people receiving dialysis at the end of 2010) has not changed substantially from 2009. In New Zealand there was a similar stability in rates of new patients, although there is greater variability reflecting a smaller population based. Rates of prevalent patients and new patients are shown in Figures 1.1 to 1.3. Further data about stock and flow is shown in Figures 1.6 to 1.14. The overall number of new transplants (846) increased by 9% in 2010 after a decrease of 5% in Australia in 2009. In 2010, there were 296 live donor transplants reported, a 9% decrease after the 8% decrease in 2009 (327 transplants). The number of new transplants remained similar in 2010 in New Zealand (110 transplants), and numbers of live donor transplants (60) have decreased since 2009. Figure 1.1 updated on 9-Mar-2012 Prevalent Patients 2006-2010 (Number Per Million Population at 31st December) 2006 2007 2008 2009 2010 Australia Total 16120 (779) 16842 (799) 17660 (822) 18317 (834) 18971 (849) No. Functioning Transplants # 6860 (331) 7113 (338) 7500 (349) 7892 (359) 8382 (375) No. Dialysis Patients 9260 (447) 9729 (462) 10160 (473) 10425 (475) 10590 (474) Proportion Home * 31% 31% 31% 30% 28% Proportion Satellite HD 43% 45% 46% 47% 50% Proportion CAPD/APD 22% 22% 22% 21% 19% New Zealand Total 3244 (775) 3354 (793) 3454 (809) 3680 (852) 3820 (874) No. Functioning Transplants # 1247 (298) 1283 (303) 1348 (316) 1400 (324) 1442 (330) No. Dialysis Patients 1997 (477) 2071 (490) 2106 (493) 2280 (528) 2378 (544) Proportion Home * 54% 52% 52% 51% 53% Proportion Satellite HD 17% 18% 19% 18% 17% Proportion CAPD/APD 38% 36% 36% 35% 35% Country of Transplant # Patients lost to follow up are not included * Proportion of all patients dialysing currently receiving home-based treatment (either PD or HD) Figure 1.2 Patient Flow Summary 2006-2010 (Number Per Million Population at 31st December) * Country of Transplant 2006 2007 2008 2009 2010 Australia Total New Patients 2432 (118) 2382 (113) 2545 (118) 2402 (109) 2257 (101) Total New Transplants * 641 (31) 615 (29) 813 (38) 773 (35) 846 (38) Living Donor Transplants 273 271 354 327 296 Subsequent Transplants 92 88 105 99 102 Total Deaths 1475 1629 1674 1687 1561 Dialysis Patients 1325 1459 1493 1538 1401 Transplant Patients 150 170 181 149 160 New Zealand Total New Patients 499 (119) 469 (111) 497 (116) 583 (135) 503 (115) Total New Transplants * 90 (21) 123 (29) 122 (29) 121 (28) 110 (25) Living Donor Transplants 49 58 69 67 60 Subsequent Transplants 10 11 11 12 6 Total Deaths 367 343 388 365 353 Dialysis Patients 333 296 360 331 319 Transplant Patients 34 47 28 34 34 1-2

Figure 1.3 Figure 1.4 Figure 1.5 1-3

ANZDATA Registry 2011 Report Figure 1.6 Figure 1.7 The incident rate among Australian Aboriginal, Maori and Pacific People is substantially higher than among non-indigenous people. However, among Australian Aboriginal people the incidence rate has clearly stabilised over the past 5 years (after a long period of steady increase since 1990). In New Zealand, rates among Maori are stable, while those among Pacific Peoples are increasing. Lower rates of transplantation, leads to higher rates of prevalent dialysis patients (Figure 1.8). Figure 1.8 Prevalence and Incidence by Indigenous Racial Origin, 2006-2010 (Number Per Million Population Per Year for Patients) Aboriginal and Torres Strait Islanders Combined Race 2006 2007 2008 2009 2010 Australia Aboriginal and Torres Strait Islanders New Zealand Maori New Patients 221 (428) 239 (453) 251 (466) 195 (355) 198 (353) Dialysis 989 (1916) 1092 (2072) 1159 (2153) 1177 (2141) 1208 (2151) Functioning Transplants * 148 (287) 148 (281) 159 (295) 160 (291) 177 (315) Transplant Operations 27 (52) 18 (34) 31 (58) 24 (44) 28 (50) Deaths 140 (271) 134 (254) 164 (305) 174 (316) 160 (285) New Patients 169 (271) 147 (232) 157 (244) 176 (270) 154 (232) Dialysis 684 (1096) 687 (1085) 688 (1070) 724 (1109) 759 (1143) Functioning Transplants * 111 (178) 113 (178) 117 (182) 127 (194) 138 (208) Transplant Operations 10 (16) 17 (27) 12 (19) 19 (29) 20 (30) Deaths 125 (200) 134 (212) 152 (236) 126 (193) 114 (172) Pacific People New Patients 79 (262) 77 (248) 87 (273) 103 (314) 106 (315) Dialysis 371 (1231) 409 (1318) 433 (1357) 485 (1480) 541 (1608) Functioning Transplants * 77 (255) 78 (251) 85 (266) 87 (265) 89 (265) Transplant Operations 7 (23) 6 (19) 10 (31) 6 (18) 9 (27) Deaths 54 (179) 34 (110) 55 (172) 48 (146) 50 (149) * By Transplanting Country 1-4

Figure 1.9 National and State Stock and Flow 1-Jan-2010 to 31-Dec-2010 (31-Dec-2009 Figures) State New Patients Transplant Operations * Dialysis Deaths Transplant Dialysis Dependent + Functioning Transplants # * + Queensland 439 (491) 141 (136) 293 (311) 36 (29) 1994 (1944) 1631 (1567) 3625 (3511) New South Wales 690 (747) 239 (223) 448 (497) 53 (54) 3441 (3374) 2376 (2232) 5817 (5606) Aust. Capital Territory 53 (41) 21 (14) 26 (27) 3 (4) 245 (239) 215 (199) 460 (438) Victoria 563 (541) 247 (211) 297 (347) 25 (21) 2598 (2513) 2186 (2028) 4784 (4541) Tasmania 47 (57) 31 (20) 28 (27) 2 (1) 192 (194) 203 (190) 395 (384) South Australia 175 (205) 82 (82) 114 (107) 19 (19) 674 (670) 911 (861) 1585 (1531) Northern Territory 64 (72) 5 (5) 43 (45) 0 (4) 439 (418) 69 (68) 508 (486) Western Australia 226 (243) 80 (82) 152 (177) 56 (51) 1007 (989) 818 (781) 1825 (1770) Australia 2257 (2402) 846 (773) 1401 (1538) 160 (149) 10590 (10341) 8409 (7926) 18999 (18267) Total New Zealand 503 (583) 110 (121) 319 (331) 34 (34) 2378 (2260) 1415 (1379) 3793 (3639) # Patients lost to follow-up are not included * Resident State + Point Prevalence at 31 December Figure 1.10 Prevalent Transplant and Dialysis Patients 1985 to 2010 Country of Transplant # Patients Lost of Follow-up are not included (Number Per Million Population at 31 December) Australia New Zealand Year Transplant # Dialysis Total Transplant # Dialysis Total 1985 2163 (137) 2230 (141) 4393 (278) 377 (114) 402 (122) 779 (236) 1986 2392 (149) 2339 (146) 4731 (295) 426 (129) 402 (121) 828 (250) 1987 2574 (158) 2526 (155) 5100 (314) 452 (135) 437 (131) 889 (266) 1988 2798 (169) 2675 (162) 5473 (331) 484 (145) 482 (144) 966 (289) 1989 3054 (182) 2750 (164) 5804 (345) 531 (158) 527 (156) 1058 (314) 1990 3265 (191) 2956 (173) 6221 (365) 579 (170) 557 (163) 1136 (333) 1991 3493 (202) 3138 (182) 6631 (384) 607 (174) 630 (180) 1237 (354) 1992 3699 (211) 3383 (193) 7082 (405) 677 (192) 674 (191) 1351 (382) 1993 3872 (219) 3703 (210) 7575 (429) 705 (197) 721 (202) 1426 (399) 1994 4064 (228) 4099 (230) 8163 (457) 731 (202) 784 (216) 1515 (418) 1995 4236 (234) 4518 (250) 8754 (484) 783 (213) 850 (231) 1633 (444) 1996 4449 (243) 4882 (267) 9331 (510) 824 (221) 934 (250) 1758 (471) 1997 4697 (254) 5190 (280) 9887 (534) 882 (233) 1017 (269) 1899 (502) 1998 4921 (263) 5536 (296) 10457 (559) 936 (245) 1126 (295) 2062 (540) 1999 5091 (269) 6019 (318) 11110 (587) 983 (256) 1230 (321) 2213 (577) 2000 5294 (276) 6409 (335) 11703 (611) 1023 (265) 1331 (345) 2354 (610) 2001 5507 (284) 6851 (353) 12358 (637) 1063 (273) 1462 (376) 2525 (650) 2002 5782 (294) 7263 (370) 13045 (664) 1116 (282) 1594 (403) 2710 (686) 2003 6003 (302) 7719 (388) 13722 (690) 1168 (290) 1711 (425) 2879 (715) 2004 6292 (313) 8004 (398) 14296 (710) 1221 (299) 1774 (434) 2995 (733) 2005 6545 (321) 8640 (424) 15185 (745) 1239 (300) 1878 (454) 3117 (754) 2006 6860 (331) 9260 (447) 16120 (779) 1247 (298) 1997 (477) 3244 (775) 2007 7113 (338) 9729 (462) 16842 (799) 1283 (303) 2071 (490) 3354 (793) 2008 7500 (349) 10160 (473) 17660 (822) 1348 (316) 2106 (493) 3454 (809) 2009 7892 (359) 10425 (475) 18317 (834) 1400 (324) 2280 (528) 3680 (852) 2010 8382 (375) 10590 (474) 18972 (849) 1442 (330) 2378 (544) 3820 (874) 1-5

ANZDATA Registry 2011 Report There is substantial variation in incidence rates and especially transplant rates leading to differences in the balance between dialysis and transplantation in various States (Figure 1.11 to 1.14). In 2010 Tasmania joined South Australia as states with a greater number of prevalent transplants than dialysis patients. Figure 1.11 Comparison of Prevalent Transplant and Dialysis Dependent Patients 2006-2010 (Number Per Million Population at 31 December) Transplants ** 2006 2007 2008 2009 2010 Queensland 1356 (331) 1403 (334) 1483 (344) 1556 (351) 1631 (361) New South Wales* 1992 (301) 2034 (304) 2133 (314) 2234 (323) 2376 (338) Aust. Capital Territory* 188 (347) 193 (351) 197 (353) 198 (349) 215 (373) Victoria 1688 (329) 1766 (338) 1887 (354) 2028 (372) 2186 (394) Tasmania 154 (314) 165 (335) 177 (355) 190 (378) 203 (400) South Australia 746 (476) 784 (494) 830 (517) 862 (531) 911 (554) Northern Territory 73 (347) 78 (363) 74 (336) 67 (296) 69 (300) Western Australia 681 (331) 703 (333) 744 (342) 782 (348) 818 (356) Australia 6878 (332) 7126 (338) 7525 (350) 7917 (360) 8409 (376) New Zealand 1229 (294) 1270 (300) 1323 (310) 1375 (318) 1415 (324) ** By Resident State and Country Dialysis Queensland 1704 (417) 1809 (431) 1885 (438) 1957 (442) 1994 (442) New South Wales* 3025 (458) 3192 (477) 3356 (493) 3408 (493) 3441 (490) Aust. Capital Territory* 206 (380) 215 (391) 235 (421) 239 (421) 245 (425) Victoria 2348 (458) 2411 (462) 2482 (466) 2524 (463) 2598 (468) Tasmania 163 (333) 175 (355) 179 (359) 198 (393) 192 (378) South Australia 604 (385) 626 (395) 631 (393) 682 (420) 674 (410) Northern Territory 334 (1586) 368 (1713) 398 (1805) 417 (1844) 439 (1911) Western Australia 876 (425) 933 (442) 994 (457) 1000 (445) 1007 (439) Australia 9260 (447) 9729 (462) 10160 (473) 10425 (475) 10590 (474) New Zealand 1997 (477) 2071 (490) 2106 (493) 2280 (528) 2378 (544) * NSW population excludes residents of the Southern Area Health Service * ACT population includes residents of the Southern Area Health Service (Medical services in the ACT service this Southern Area Region) Transplanted patients lost to follow up have been excluded Figure 1.12 Figure 1.13 1-6

Figure 1.14 Comparison of Transplant and Dialysis Dependent Patients 2006-2010 1-7